Molecular Structure image

Pipeline

IndicationProgram / Regulatory PathwayPreclinicalPhase IPhase IIPhase IIINDAFDA ApprovalPartner
Opioid OverdoseNARCAN® Nasal SprayApproved
Opioid OverdoseOPNT003 Nalmefene Nasal Spray
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval
Alcohol Use DisorderOPNT002 Opioid Antagonist Nasal Spray
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval
Acute Cannabinoid OverdoseOPNT004 Drinabant (CB-1 Antagonist)
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval
Sanofi logo
Opioid Use DisorderOPNT005 Heroin Vaccine: hapten + liposome adjuvant
Preclinical
Phase I
Phase II
Phase III
NDA
FDA Approval
WRNMMC Logo